Outcome Measures in Multiple Sclerosis

被引：5
|
作者：
Bermel, Robert [1 ]
Waldman, Amy [2 ]
Mowry, Ellen M. [3 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44195 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA
来源：
MULTIPLE SCLEROSIS INTERNATIONAL | 2014年 / 2014卷
关键词：
D O I：
10.1155/2014/439375
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The measure tells the tale: Clinical outcome measures in multiple sclerosis
    Hulst, Hanneke E.
    Thompson, Alan J.
    Geurts, Jeroen J. G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (05) : 626 - 627
  • [22] The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis
    Brenton, J. Nicholas
    Koshiya, Hitoshi
    Woolbright, Emma
    Goldman, Myla D.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (02)
  • [23] Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis
    Molenaar, Pam C. G.
    Noteboom, Samantha
    van Nederpelt, David R.
    Krijnen, Eva A.
    Jelgerhuis, Julia R.
    Lam, Ka-Hoo
    Druijff-van de Woestijne, Gerrieke B.
    Meijer, Kim A.
    van Oirschot, Pim
    de Jong, Brigit A.
    Brouwer, Iman
    Jasperse, Bas
    de Groot, Vincent
    Uitdehaag, Bernard M. J.
    Schoonheim, Menno M.
    Strijbis, Eva M. M.
    Killestein, Joep
    JOURNAL OF NEUROLOGY, 2024, : 5958 - 5968
  • [24] Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
    Bernard M. J. Uitdehaag
    CNS Drugs, 2018, 32 : 543 - 558
  • [25] Comparison of outcome measures in interferon beta studies in relapsing multiple sclerosis
    O'Connor, P
    NEUROLOGY, 1999, 52 (06) : A498 - A498
  • [26] Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review
    Sellitto, Giovanni
    Morelli, Alessia
    Bassano, Susanna
    Conte, Antonella
    Baione, Viola
    Galeoto, Giovanni
    Berardi, Anna
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 625 - 646
  • [27] Appropriate design and outcome measures in multiple sclerosis clinical trials - Response
    Khan, OA
    Tselis, AC
    Kamholz, JA
    Garbern, JY
    Lewis, RA
    Lisak, RP
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (05) : 505 - 506
  • [28] OUTCOME MEASURES FOR CLINICAL-TRIALS IN MULTIPLE-SCLEROSIS - REPLY
    MCFARLAND, HF
    ANNALS OF NEUROLOGY, 1992, 31 (01) : 116 - 117
  • [29] Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
    Uitdehaag, Bernard M. J.
    CNS DRUGS, 2018, 32 (06) : 543 - 558
  • [30] Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis
    Koch, Marcus W.
    Mostert, Jop
    Repovic, Pavle
    Bowen, James D.
    Uitdehaag, Bernard
    Cutter, Gary
    NEUROLOGY, 2021, 96 (01) : E111 - E120
12345